Posted by Michael Wonder on 20 May 2026
EMA publishes agenda for 18-21 May 2026 CHMP meeting
18 May 2026 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Liraglutide
- Clostridium botulinum, serotype E, neurotoxin
- Copper (64Cu) oxodotreotide
- Colchicine
- Alpelisib
- Ranibizumab
